The recent communication regarding the recent Anti-SARS-CoV-2 Total assay in Tampa has brought about many questions as hospitals and blood centers prepare to order the testing. We've put together a FAQ document to clarify what we know today. We will update the document as we get more information on existing questions and as new questions get asked, and will update the blog with the revised FAQ document.
Thanks for your support as we work to rapidly get this testing available to you. You can find the FAQ document here: CTS COVID-19 Questions and Answers
As winter weather continues to move through parts of the US, we would like to remind you it may be n...
CTS Spotlight at 2018 AABB Annual Meeting Sunday, October 14, 2018 at 1:30 PM: Scientific Oral ...
The COVID-19 pandemic has unveiled the huge challenges and risks health workers are facing globally ...
This is the first update to the original CTS communication distributed on July 6th. As previously co...
Seasonal monitoring of epidemic triggers for West Nile Virus (WNV) NAT tested donations will begin J...
The FDA Guidance ZIKV video for the webinar held on 08/15/18 has been posted in the Wh...